Stock 6612 ICARES MEDICUS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials ICARES Medicus, Inc.

Equities

6612

TW0006612005

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-05-02 pm EDT 		5-day change 1st Jan Change
131 TWD -2.24% Intraday chart for ICARES Medicus, Inc. -1.50% +3.97%
Mar. 14 ICARES Medicus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 ICARES Medicus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,017 2,932 2,101 2,337 2,774 4,934
Enterprise Value (EV) 1 1,621 2,652 1,843 1,998 2,353 4,109
P/E ratio 27.5 x 35.9 x 40.5 x 39.5 x 21.4 x 45.2 x
Yield 0.82% 0.58% 0.16% 0.73% 1.23% 0.16%
Capitalization / Revenue 6.12 x 6.99 x 5.79 x 5.93 x 5.42 x 8.15 x
EV / Revenue 4.92 x 6.32 x 5.08 x 5.07 x 4.6 x 6.79 x
EV / EBITDA 16.7 x 21.5 x 18.5 x 18.7 x 16.7 x 31.8 x
EV / FCF 48.4 x 92.7 x 35.8 x 25.2 x 245 x -94.7 x
FCF Yield 2.07% 1.08% 2.8% 3.97% 0.41% -1.06%
Price to Book 3.54 x 4.7 x 3.16 x 3.13 x 3.16 x 3.13 x
Nbr of stocks (in thousands) 33,226 33,745 33,732 33,970 34,164 39,160
Reference price 2 60.70 86.90 62.30 68.80 81.20 126.0
Announcement Date 3/22/19 3/18/20 3/31/21 3/22/22 3/20/23 3/14/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 329.3 419.4 362.7 393.9 511.9 605.5
EBITDA 1 96.79 123.5 99.58 106.9 141.2 129.3
EBIT 1 86.19 105.6 78.52 87.85 123.2 108.6
Operating Margin 26.17% 25.17% 21.65% 22.3% 24.07% 17.93%
Earnings before Tax (EBT) 1 100.4 109 73.76 73.19 143.1 113.3
Net income 1 70.45 81.02 51.91 58.6 128.9 97.73
Net margin 21.4% 19.32% 14.31% 14.88% 25.19% 16.14%
EPS 2 2.210 2.420 1.540 1.740 3.790 2.790
Free Cash Flow 1 33.51 28.6 51.52 79.27 9.6 -43.38
FCF margin 10.18% 6.82% 14.21% 20.12% 1.88% -7.16%
FCF Conversion (EBITDA) 34.62% 23.15% 51.74% 74.17% 6.8% -
FCF Conversion (Net income) 47.56% 35.29% 99.26% 135.26% 7.45% -
Dividend per Share 2 0.5000 0.5000 0.1000 0.5000 1.000 0.2000
Announcement Date 3/22/19 3/18/20 3/31/21 3/22/22 3/20/23 3/14/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 396 280 258 339 421 825
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 33.5 28.6 51.5 79.3 9.6 -43.4
ROE (net income / shareholders' equity) 15.7% 11.2% 5.45% 4.91% 12.6% 4.94%
ROA (Net income/ Total Assets) 10.6% 9.36% 5.98% 6.05% 7.66% 4.6%
Assets 1 666.3 865.5 867.5 968 1,682 2,126
Book Value Per Share 2 17.20 18.50 19.70 22.00 25.70 40.30
Cash Flow per Share 2 12.00 9.200 8.340 10.50 8.330 9.740
Capex 1 6.08 93.4 9.11 5.39 31.4 71
Capex / Sales 1.84% 22.27% 2.51% 1.37% 6.14% 11.72%
Announcement Date 3/22/19 3/18/20 3/31/21 3/22/22 3/20/23 3/14/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ICARES MEDICUS, INC. Stock ICARES Medicus, Inc.
+3.97% 159M
ABBOTT LABORATORIES Stock Abbott Laboratories
-3.79% 184B
MEDTRONIC PLC Stock Medtronic plc
-0.84% 108B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.75% 67.8B
DEXCOM, INC. Stock DexCom, Inc.
+3.45% 51.05B
CENCORA, INC. Stock Cencora, Inc.
+9.04% 44.67B
HOYA CORPORATION Stock Hoya Corporation
+3.40% 41.78B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+3.21% 26.78B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+3.66% 26.59B
TERUMO CORPORATION Stock Terumo Corporation
+15.23% 25.86B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 6612 Stock
  4. Financials ICARES Medicus, Inc.